News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) to Reconsider Price for Stake in Nigerian Unit



7/24/2013 7:57:25 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline Plc (GSK), the U.K.’s biggest drug-maker, will consult Nigerian shareholders and that country’s regulator before making a fresh bid to increase its stake in the local unit. The company, which is at the center of a bribery and corruption probe in China, withdrew a plan yesterday “after the parties did not conclude on where to pitch the price,” GlaxoSmithKline Consumer Nigeria Plc (GLAXOSMI) Chairman Olusegun Osunkeye told reporters in Lagos, the commercial capital, today. “Glaxo will consult with Nigerian shareholders and regulator to come back with acceptable plan.”

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Financial Times
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES